C5orf34, on the other hand, was shown to be less expressed in several malignancies, including leukemia, prostate cancer, lymphoma, breast cancer, ovarian cancer, and central nervous system cancer (Figure 1A). Here, C5orf34 is linked to Familial prostate cancer.